{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:26:35Z","timestamp":1698780395080},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Anti-streptavidin antibodies are causal determinants of analytical interference during Thyroid function tests, and numerous reports have detailed such interference, with anti-streptavidin antibodies attracting attention.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We conducted a straightforward investigation of interference due to anti-streptavidin antibodies, with a case of a 60-year-old Japanese man who consulted our department for inconsistencies between his clinical course and Thyroid function tests. Experiments were conducted using Cobas8000 e602, which employs assay procedures with pre-wash to evaluate FT4 and FT3 levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>To our knowledge, this is the first published report to clearly investigate such interferences using a combination of polyethylene glycol precipitation, heterophilic blocking tube precipitation, streptavidin-coated magnetic particle precipitation, and different instruments with or without pre-wash. Clinicians should consider that interferences caused by anti-streptavidin antibodies could lead to a misdiagnosis of thyrotoxicosis. Moreover, discussions between laboratory specialists, clinicians, and manufacturers are required to identify interferences and avoid unnecessary examinations and inappropriate treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13044-021-00108-y","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T07:21:06Z","timestamp":1625901666000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Falsely diagnosed thyrotoxicosis caused by anti-streptavidin antibodies and pre-wash procedures"],"prefix":"10.1186","volume":"14","author":[{"given":"Takuya","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokutaro","family":"Itaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suwanai","family":"Hirotsugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumpei","family":"Shikuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Odawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,10]]},"reference":[{"issue":"1","key":"108_CR1","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1515\/cclm-2015-0350","volume":"54","author":"L Peltier","year":"2016","unstructured":"Peltier L, Massart C, Moineau MP, Delhostal A, Roudaut N. Anti-streptavidin interferences in Roche thyroid immunoassays: a case report. Clin Chem Lab Med. 2016;54(1):e11\u20134. https:\/\/doi.org\/10.1515\/cclm-2015-0350.","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"108_CR2","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.5858\/arpa.2012-0270-CR","volume":"137","author":"NJ Rulander","year":"2013","unstructured":"Rulander NJ, Cardamone D, Senior M, Snyder PJ, Master SR. Interference from anti-streptavidin antibody. Arch Pathol Lab Med. 2013;137(8):1141\u20136. https:\/\/doi.org\/10.5858\/arpa.2012-0270-CR.","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"108_CR3","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1210\/jc.2016-1971","volume":"101","author":"MS Elston","year":"2016","unstructured":"Elston MS, Sehgal S, Du Toit S, Yarndley T, Conaglen JV. Factitious Graves' disease due to biotin immunoassay interference-a case and review of the literature. J Clin Endocrinol Metab. 2016;101(9):3251\u20135. https:\/\/doi.org\/10.1210\/jc.2016-1971.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"108_CR4","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1089\/thy.2017.0673","volume":"28","author":"L Lam","year":"2018","unstructured":"Lam L, Bagg W, Smith G, Chiu WW, Middleditch MJ, Lim JC, et al. Apparent hyperthyroidism caused by biotin-like interference from IgM anti-streptavidin antibodies. Thyroid. 2018;28(8):1063\u20137. https:\/\/doi.org\/10.1089\/thy.2017.0673.","journal-title":"Thyroid"},{"issue":"7","key":"108_CR5","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1515\/cclm-2017-1027","volume":"56","author":"J Favresse","year":"2018","unstructured":"Favresse J, Lardinois B, Nassogne MC, Preumont V, Maiter D, Gruson D. Anti-streptavidin antibodies mimicking heterophilic antibodies in thyroid function tests. Clin Chem Lab Med. 2018;56(7):e160\u20133. https:\/\/doi.org\/10.1515\/cclm-2017-1027.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"108_CR6","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1515\/cclm-2019-0525","volume":"58","author":"I Ruth","year":"2020","unstructured":"Ruth I, Mathieu E, Burniat A, Fage D, Cotton F, Wolff F. Interferences in free thyroxine concentration using the Roche analytical platform: improvement of the third generation? Clin Chem Lab Med. 2020;58(2):e36\u20139. https:\/\/doi.org\/10.1515\/cclm-2019-0525.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"108_CR7","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1515\/cclm-2019-0845","volume":"58","author":"Y Wouters","year":"2020","unstructured":"Wouters Y, Oosterbos J, Reynaert N, Penders J. Alarmed by misleading interference in free T3 and free T4 assays: a new case of anti-streptavidin antibodies. Clin Chem Lab Med. 2020;58(3):e69\u201371. https:\/\/doi.org\/10.1515\/cclm-2019-0845.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"108_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1507\/endocrj.K08E-361","volume":"56","author":"H Sakai","year":"2009","unstructured":"Sakai H, Fukuda G, Suzuki N, Watanabe C, Odawara M. Falsely elevated thyroid-stimulating hormone (TSH) level due to macro-TSH. Endocr J. 2009;56(3):435\u201340. https:\/\/doi.org\/10.1507\/endocrj.K08E-361.","journal-title":"Endocr J"},{"issue":"10","key":"108_CR9","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1515\/cclm-2018-1355","volume":"57","author":"JL Bayart","year":"2019","unstructured":"Bayart JL, Favresse J, Melnik E, Lardinois B, Fillee C, Maiter D, et al. Erroneous thyroid and steroid hormones profile due to anti-streptavidin antibodies. Clin Chem Lab Med. 2019;57(10):e255\u20138. https:\/\/doi.org\/10.1515\/cclm-2018-1355.","journal-title":"Clin Chem Lab Med"},{"key":"108_CR10","doi-asserted-by":"publisher","unstructured":"Verougstraete N, Berth M, Vaneechoutte M, Delanghe J, Callewaert N. Interference of anti-streptavidin antibodies in immunoassays: a very rare phenomenon or a more common finding? Clin Chem Lab Med. 2020;58(10):1673\u201380.\u00a0https:\/\/doi.org\/10.1515\/cclm-2019-1064.","DOI":"10.1515\/cclm-2019-1064"}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-021-00108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13044-021-00108-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-021-00108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T07:21:55Z","timestamp":1625901715000},"score":1,"resource":{"primary":{"URL":"https:\/\/thyroidresearchjournal.biomedcentral.com\/articles\/10.1186\/s13044-021-00108-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,10]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1186\/s13044-021-00108-y","relation":{},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,10]]},"assertion":[{"value":"5 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents of the case-patient were obtained in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}